290 related articles for article (PubMed ID: 28805484)
1. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
[TBL] [Abstract][Full Text] [Related]
2. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
[TBL] [Abstract][Full Text] [Related]
3. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
4. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
5. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
7. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX
Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
9. Grem2 mediates podocyte apoptosis in high glucose milieu.
Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
[TBL] [Abstract][Full Text] [Related]
10. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
11. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
12. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
13. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
14. Fuxin Granules ameliorate diabetic nephropathy in db/db mice through TGF-β1/Smad and VEGF/VEGFR2 signaling pathways.
Zheng W; Qian C; Xu F; Cheng P; Yang C; Li X; Lu Y; Wang A
Biomed Pharmacother; 2021 Sep; 141():111806. PubMed ID: 34246190
[TBL] [Abstract][Full Text] [Related]
15. Suramin: a potential therapy for diabetic nephropathy.
Korrapati MC; Howell LA; Shaner BE; Megyesi JK; Siskind LJ; Schnellmann RG
PLoS One; 2013; 8(9):e73655. PubMed ID: 24040012
[TBL] [Abstract][Full Text] [Related]
16. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
Zhang X; Guan T; Yang B; Gu HF; Chi Z
Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
[TBL] [Abstract][Full Text] [Related]
17. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.
Ninichuk V; Khandoga AG; Segerer S; Loetscher P; Schlapbach A; Revesz L; Feifel R; Khandoga A; Krombach F; Nelson PJ; Schlöndorff D; Anders HJ
Am J Pathol; 2007 Apr; 170(4):1267-76. PubMed ID: 17392166
[TBL] [Abstract][Full Text] [Related]
18. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
20. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]